Literature DB >> 16548175

[Protective effects of hirudin on acute experimental intracerebral hemorrhage].

Ying Zhang1, Jia-chun Feng, Jiang Wu, Ya-ping Ge, Wei-hua Zhang, Li-hua Hu, Wei Han.   

Abstract

OBJECTIVE: To explore the protective effects of hirudin on acute experimental intracerebral hemorrhage (ICH) by observing the changes of histologic pathology and brain water content as well as GFAP-positive cells in the perihematomal brain regions.
METHOD: The models of rat ICH were made with infusion of autologous blood into the right neucleus caudatus. The rats were divided randomly into control group, intracerebral hemorrhage group and treating group with hirudin. Brain water content was measured, and pathological and GFAP changes were observed. RESULT: The pathological impairation after ICH were gradually deteriorated and peaked at the third day. Brain water content after ICH was gradually increased and obviously after one day(P < 0.05) and peaked at the third day. GFAP-positive cells were gradually increased and peaked at the seventh day after ICH. In the treating groups, the pathological impairation and brain water content as well as the GFAP-positive cells were decreased as compared to those in the intracerebral hemorrhage group and the control group. And the positive correlation between GFAP-positive cell numbers and brain water content were shown by linear regression.
CONCLUSION: The local administration of hirudin, a special inhibitor of thrombin, has protective effects within the first week after ICH.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16548175

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  2 in total

1.  Astrogliosis: a target for intervention in intracerebral hemorrhage?

Authors:  Sangeetha Sukumari-Ramesh; Cargill H Alleyne; Krishnan M Dhandapani
Journal:  Transl Stroke Res       Date:  2012-04-14       Impact factor: 6.829

Review 2.  A Systematic Review and Meta-Analysis on the Treatment of Cerebral Hemorrhage with NaoXueShu Oral Liquid.

Authors:  Lijun Wu; Yanda Li; Xiaofeng Wang; Xiaomeng Ren; Haiyan Zhu; Yikun Sun; Yanwei Xing; Lingqun Zhu; Yonghong Gao; Hongcai Shang
Journal:  Biomed Res Int       Date:  2017-05-29       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.